{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:32:45Z","timestamp":1790947965940,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"New National Excellence Program of the Ministry for Innovation and Technology","award":["\u00daNKP-20-3-I"],"award-info":[{"award-number":["\u00daNKP-20-3-I"]}]},{"name":"J\u00e1nos Bolyai Research Scholarship of the Hungarian Academy of Sciences","award":["RRF-2.3.1-21-2022-00003"],"award-info":[{"award-number":["RRF-2.3.1-21-2022-00003"]}]},{"name":"Ministry of Culture and Innovation of Hungary from the National Research, Development and Innovation Fund","award":["STARTING 150493"],"award-info":[{"award-number":["STARTING 150493"]}]},{"name":"New National Excellence Program of the Ministry for Culture and Innovation","award":["EK\u00d6P-2024-180"],"award-info":[{"award-number":["EK\u00d6P-2024-180"]}]},{"name":"University Research Scholarship Programme of the Ministry for Culture and Innovation from the source of the National Research, Development and Innovation Fund","award":["2025-2.1.1-EK\u00d6P-2025-00014"],"award-info":[{"award-number":["2025-2.1.1-EK\u00d6P-2025-00014"]}]},{"DOI":"10.13039\/501100002332","name":"Semmelweis Egyetem","doi-asserted-by":"publisher","award":["Semmelweis 250+ Excellence PhD Scholarship"],"award-info":[{"award-number":["Semmelweis 250+ Excellence PhD Scholarship"]}],"id":[{"id":"10.13039\/501100002332","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s13555-026-01872-1","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T17:28:47Z","timestamp":1785432527000},"page":"4631-4649","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cumulative Duration of Severe Psoriasis: A Novel Cardiovascular Risk Predictor for Dermatologists"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1813-2285","authenticated-orcid":false,"given":"Bernadett B.","family":"Huszti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00e9mi \u00c1.","family":"Galajda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seo-Ho","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1ria V.","family":"Kolonics","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9va A.","family":"Piros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Luk\u00e1cs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e1lint","family":"Szilveszter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borb\u00e1la","family":"Vattay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kl\u00e1ra","family":"Szalai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e1s","family":"B\u00e1nv\u00f6lgyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lajos V.","family":"Kem\u00e9ny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e1l","family":"Maurovich Horvat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienn K.","family":"Po\u00f3r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9la","family":"Merkely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0744-8989","authenticated-orcid":false,"given":"P\u00e9ter","family":"Holl\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"1872_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00579","volume":"9","author":"W-H Boehncke","year":"2018","unstructured":"Boehncke W-H. Systemic inflammation and cardiovascular comorbidity in psoriasis patients: causes and consequences. Front Immunol. 2018;9:579.","journal-title":"Front Immunol"},{"key":"1872_CR2","doi-asserted-by":"publisher","first-page":"16082","DOI":"10.1038\/nrdp.2016.82","volume":"2","author":"JE Greb","year":"2016","unstructured":"Greb JE, Goldminz AM, Elder JT, et al. Psoriasis. Nat Rev Dis Primers. 2016;2:16082.","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"1872_CR3","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/s41569-024-01097-9","volume":"22","author":"JM Gelfand","year":"2024","unstructured":"Gelfand JM, Song WB, Langan SM, Garshick MS. Cardiodermatology: the heart of the connection between the skin and cardiovascular disease. Nat Rev Cardiol. 2024;22(5):354\u201371.","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"1872_CR4","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","volume":"76","author":"J Takeshita","year":"2017","unstructured":"Takeshita J, Grewal S, Langan SM, et al. Psoriasis and comorbid diseases: epidemiology. J Am Acad Dermatol. 2017;76(3):377\u201390.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"1872_CR5","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.jaad.2013.06.053","volume":"69","author":"IM Miller","year":"2013","unstructured":"Miller IM, Ellervik C, Yazdanyar S, Jemec GBE. Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors. J Am Acad Dermatol. 2013;69(6):1014\u201324.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"1872_CR6","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1365-2133.1978.tb02012.x","volume":"99","author":"CJ McDonald","year":"1978","unstructured":"McDonald CJ, Calabresi P. Psoriasis and occlusive vascular disease. Br J Dermatol. 1978;99(5):469\u201375.","journal-title":"Br J Dermatol"},{"key":"1872_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.667690","volume":"12","author":"W Su","year":"2021","unstructured":"Su W, Zhao Y, Wei Y, Zhang X, Ji J, Yang S. Exploring the pathogenesis of psoriasis complicated with atherosclerosis via microarray data analysis. Front Immunol. 2021;12:667690.","journal-title":"Front Immunol"},{"issue":"6","key":"1872_CR8","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/jdv.18044","volume":"36","author":"JJ Wu","year":"2022","unstructured":"Wu JJ, Kavanaugh A, Lebwohl MG, Gniadecki R, Merola JF. Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis. J Eur Acad Dermatol Venereol. 2022;36(6):797\u2013806.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"1872_CR9","doi-asserted-by":"publisher","first-page":"13831","DOI":"10.1038\/s41598-017-14365-1","volume":"7","author":"NN Mehta","year":"2017","unstructured":"Mehta NN, Teague HL, Swindell WR, et al. IFN-\u03b3 and TNF-\u03b1 synergism may provide a link between psoriasis and inflammatory atherogenesis. Sci Rep. 2017;7(1):13831.","journal-title":"Sci Rep"},{"issue":"8","key":"1872_CR10","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1111\/jdv.16273","volume":"34","author":"A Egeberg","year":"2020","unstructured":"Egeberg A, Gisondi P, Carrascosa JM, Warren RB, Mrowietz U. The role of the interleukin-23\/Th17 pathway in cardiometabolic comorbidity associated with psoriasis. J Eur Acad Dermatol Venereol. 2020;34(8):1695\u2013706.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"1872_CR11","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/j.1600-0625.2011.01308.x","volume":"20","author":"AW Armstrong","year":"2011","unstructured":"Armstrong AW, Voyles SV, Armstrong EJ, Fuller EN, Rutledge JC. A tale of two plaques: convergent mechanisms of T-cell-mediated inflammation in psoriasis and atherosclerosis. Exp Dermatol. 2011;20(7):544\u20139.","journal-title":"Exp Dermatol"},{"issue":"10","key":"1872_CR12","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1038\/jid.2009.112","volume":"129","author":"JM Gelfand","year":"2009","unstructured":"Gelfand JM, Dommasch ED, Shin DB, et al. The risk of stroke in patients with psoriasis. J Invest Dermatol. 2009;129(10):2411\u20138.","journal-title":"J Invest Dermatol"},{"issue":"13","key":"1872_CR13","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1093\/eurheartj\/ehs092","volume":"33","author":"J Perk","year":"2012","unstructured":"Perk J, De Backer G, Gohlke H, et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012): the fifth joint task force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2012;33(13):1635\u2013701 (Erratum in: Eur Heart J. 2012;33(17):2126).","journal-title":"Eur Heart J"},{"issue":"5","key":"1872_CR14","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1007\/s12325-020-01346-6","volume":"37","author":"W Masson","year":"2020","unstructured":"Masson W, Lobo M, Molinero G. Psoriasis and cardiovascular risk: a comprehensive review. Adv Ther. 2020;37(5):2017\u201333.","journal-title":"Adv Ther"},{"issue":"3","key":"1872_CR15","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1016\/j.ijcard.2013.01.197","volume":"168","author":"M Gaeta","year":"2013","unstructured":"Gaeta M, Castelvecchio S, Ricci C, Pigatto P, Pellissero G, Cappato R. Role of psoriasis as independent predictor of cardiovascular disease: a meta-regression analysis. Int J Cardiol. 2013;168(3):2282\u20138.","journal-title":"Int J Cardiol"},{"issue":"14","key":"1872_CR16","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1001\/jama.296.14.1735","volume":"296","author":"JM Gelfand","year":"2006","unstructured":"Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA. 2006;296(14):1735\u201341.","journal-title":"JAMA"},{"issue":"4","key":"1872_CR17","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1177\/1203475415602842","volume":"20","author":"YC Lai","year":"2016","unstructured":"Lai YC, Yew YW. Psoriasis as an independent risk factor for cardiovascular disease. J Cutan Med Surg. 2016;20(4):327\u201333.","journal-title":"J Cutan Med Surg"},{"issue":"13","key":"1872_CR18","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/j.jacc.2021.02.009","volume":"77","author":"MS Garshick","year":"2021","unstructured":"Garshick MS, Ward NL, Krueger JG, Berger JS. Cardiovascular risk in patients with psoriasis. J Am Coll Cardiol. 2021;77(13):1670\u201380.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"1872_CR19","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/j.1365-2133.2010.09941.x","volume":"163","author":"K Abuabara","year":"2010","unstructured":"Abuabara K, Azfar RS, Shin DB, Neimann AL, Troxel AB, Gelfand JM. Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K. Br J Dermatol. 2010;163(3):586\u201392.","journal-title":"Br J Dermatol"},{"issue":"2","key":"1872_CR20","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1365-2133.2006.07562.x","volume":"156","author":"RJ Ludwig","year":"2007","unstructured":"Ludwig RJ, Herzog C, Rostock A, et al. Psoriasis: a possible risk factor for development of coronary artery calcification. Br J Dermatol. 2007;156(2):271\u20136.","journal-title":"Br J Dermatol"},{"issue":"2","key":"1872_CR21","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.atherosclerosis.2014.11.004","volume":"237","author":"HL Staniak","year":"2014","unstructured":"Staniak HL, Bittencourt MS, De Souza Santos I, et al. Association between psoriasis and coronary calcium score. Atherosclerosis. 2014;237(2):847\u201352.","journal-title":"Atherosclerosis"},{"issue":"3","key":"1872_CR22","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/joim.12002","volume":"273","author":"KH Yiu","year":"2013","unstructured":"Yiu KH, Yeung CK, Zhao CT, et al. Prevalence and extent of subclinical atherosclerosis in patients with psoriasis. J Intern Med. 2013;273(3):273\u201382.","journal-title":"J Intern Med"},{"issue":"11","key":"1872_CR23","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1001\/jamadermatol.2016.2907","volume":"152","author":"B Mansouri","year":"2016","unstructured":"Mansouri B, Kivelevitch D, Natarajan B, et al. Comparison of coronary artery calcium scores between patients with psoriasis and type\u00a02 diabetes. JAMA Dermatol. 2016;152(11):1244\u201353.","journal-title":"JAMA Dermatol"},{"issue":"6","key":"1872_CR24","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1111\/j.1468-3083.2009.03481.x","volume":"24","author":"S El-Mongy","year":"2010","unstructured":"El-Mongy S, Fathy H, Abdelaziz A, et al. Subclinical atherosclerosis in patients with chronic psoriasis: a potential association. J Eur Acad Dermatol Venereol. 2010;24(6):661\u20136.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"1872_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1468-3083.2008.02936.x","volume":"23","author":"D Balci","year":"2009","unstructured":"Balci D, Balci A, Karazincir S, et al. Increased carotid artery intima-media thickness and impaired endothelial function in psoriasis. J Eur Acad Dermatol Venereol. 2009;23(1):1\u20136.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"9","key":"1872_CR26","volume":"11","author":"\u00c9A Piros","year":"2021","unstructured":"Piros \u00c9A, Szab\u00f3 \u00c1, Rencz F, et al. Impact of interleukin-17 inhibitor therapy on arterial intima-media thickness among severe psoriatic patients. Life (Basel). 2021;11(9):919.","journal-title":"Life (Basel)"},{"issue":"3","key":"1872_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12031162","volume":"12","author":"H Terui","year":"2023","unstructured":"Terui H, Asano Y. Biologics for reducing cardiovascular risk in psoriasis patients. J Clin Med. 2023;12(3):1162.","journal-title":"J Clin Med"},{"key":"1872_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105485","volume":"111","author":"K Kridin","year":"2025","unstructured":"Kridin K, Bieber K, Vorobyev A, et al. Biological, as opposed to classic antipsoriatic drug or apremilast, treatment mitigates the risk of death and cardiovascular disease in psoriasis. EBioMedicine. 2025;111:105485.","journal-title":"EBioMedicine"},{"issue":"4","key":"1872_CR29","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.jaad.2013.06.019","volume":"69","author":"H J\u00f3kai","year":"2013","unstructured":"J\u00f3kai H, Szakonyi J, Kont\u00e1r O, et al. Impact of effective tumor necrosis factor-alfa inhibitor treatment on arterial intima-media thickness in psoriasis: results of a pilot study. J Am Acad Dermatol. 2013;69(4):523\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"1872_CR30","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1111\/jdv.14841","volume":"32","author":"A Martinez-Lopez","year":"2018","unstructured":"Martinez-Lopez A, Blasco-Morente G, Perez-Lopez I, Tercedor-Sanchez J, Arias-Santiago S. Studying the effect of systemic and biological drugs on intima-media thickness in patients suffering from moderate and severe psoriasis. J Eur Acad Dermatol Venereol. 2018;32(9):1492\u20138.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"1872_CR31","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.117.007394","volume":"11","author":"NN Mehta","year":"2018","unstructured":"Mehta NN, Shin DB, Joshi AA, et al. Effect of 2 psoriasis treatments on vascular inflammation and novel inflammatory cardiovascular biomarkers. Circ Cardiovasc Imaging. 2018;11(6):e007394.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"9","key":"1872_CR32","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1111\/jdv.19168","volume":"37","author":"A Svedbom","year":"2023","unstructured":"Svedbom A, St\u00e5hle M. The psoriasis area and severity index is an independent risk factor for cardiovascular events: a prospective register study. J Eur Acad Dermatol Venereol. 2023;37(9):1841\u20137.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"1872_CR33","doi-asserted-by":"publisher","first-page":"775.e1","DOI":"10.1016\/j.amjmed.2011.03.028","volume":"124","author":"NN Mehta","year":"2011","unstructured":"Mehta NN, Yu Y, Pinnelas R, et al. Attributable risk estimate of severe psoriasis on major cardiovascular events. Am J Med. 2011;124(8):775.e1-6.","journal-title":"Am J Med"},{"issue":"8","key":"1872_CR34","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1093\/eurheartj\/ehp567","volume":"31","author":"NN Mehta","year":"2010","unstructured":"Mehta NN, Azfar RS, Shin DB, Neimann AL, Troxel AB, Gelfand JM. Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur Heart J. 2010;31(8):1000\u20136.","journal-title":"Eur Heart J"},{"issue":"4","key":"1872_CR35","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1159\/000343145","volume":"34","author":"PJ Touboul","year":"2012","unstructured":"Touboul PJ, Hennerici MG, Meairs S, et al. Mannheim carotid intima-media thickness and plaque consensus (2004\u20132006\u20132011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis. 2012;34(4):290\u20136.","journal-title":"Cerebrovasc Dis"},{"issue":"6","key":"1872_CR36","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.jcct.2016.10.002","volume":"10","author":"S Abbara","year":"2016","unstructured":"Abbara S, Blanke P, Maroules CD, et al. SCCT guidelines for the performance and acquisition of coronary computed tomographic angiography: a report of the society of Cardiovascular Computed Tomography Guidelines Committee: endorsed by the North American Society for Cardiovascular Imaging (NASCI). J Cardiovasc Comput Tomogr. 2016;10(6):435\u201349.","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"12 Pt A","key":"1872_CR37","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1016\/j.jacr.2016.04.024","volume":"13","author":"RC Cury","year":"2016","unstructured":"Cury RC, Abbara S, Achenbach S, et al. CAD-RADS\u2122: coronary artery disease - reporting and data system: an expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Radiology (ACR) and the North American Society for Cardiovascular Imaging (NASCI). Endorsed by the American College of Cardiology. J Am Coll Radiol. 2016;13(12 Pt A):1458-66.e9.","journal-title":"J Am Coll Radiol"},{"issue":"5","key":"1872_CR38","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.jcmg.2020.06.048","volume":"14","author":"O Dzaye","year":"2021","unstructured":"Dzaye O, Dardari ZA, Cainzos-Achirica M, et al. Warranty period of a calcium score of zero: comprehensive analysis from MESA. JACC Cardiovasc Imaging. 2021;14(5):990\u20131002.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"9","key":"1872_CR39","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1161\/CIRCULATIONAHA.115.018524","volume":"133","author":"MJ Blaha","year":"2016","unstructured":"Blaha MJ, Cainzos-Achirica M, Greenland P, et al. Role of coronary artery calcium score of zero and other negative risk markers for cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2016;133(9):849\u201358.","journal-title":"Circulation"},{"issue":"8","key":"1872_CR40","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.jcmg.2015.01.025","volume":"8","author":"V Valenti","year":"2015","unstructured":"Valenti V, \u00d3 Hartaigh B, Heo R, et al. A 15-year warranty period for asymptomatic individuals without coronary artery calcium. JACC Cardiovasc Imaging. 2015;8(8):900\u20139.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"1872_CR41","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.echo.2007.05.002","volume":"21","author":"TK Lim","year":"2008","unstructured":"Lim TK, Lim E, Dwivedi G, Kooner J, Senior R. Normal value of carotid intima-media thickness\u2013a surrogate marker of atherosclerosis: quantitative assessment by B-mode carotid ultrasound. J Am Soc Echocardiogr. 2008;21(2):112\u20136.","journal-title":"J Am Soc Echocardiogr"},{"issue":"2","key":"1872_CR42","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/jdv.16926","volume":"35","author":"A Nast","year":"2021","unstructured":"Nast A, Smith C, Spuls PI, et al. EuroGuiDerm guideline on the systemic treatment of psoriasis vulgaris \u2013 part 2: specific clinical and comorbid situations. J Eur Acad Dermatol Venereol. 2021;35(2):281\u2013317.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10","key":"1872_CR43","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1038\/jid.2013.149","volume":"133","author":"EJ Samarasekera","year":"2013","unstructured":"Samarasekera EJ, Neilson JM, Warren RB, Parnham J, Smith CH. Incidence of cardiovascular disease in individuals with psoriasis: a systematic review and meta-analysis. J Invest Dermatol. 2013;133(10):2340\u20136.","journal-title":"J Invest Dermatol"},{"issue":"4","key":"1872_CR44","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.jaad.2017.06.028","volume":"77","author":"A Egeberg","year":"2017","unstructured":"Egeberg A, Skov L, Joshi AA, et al. The relationship between duration of psoriasis, vascular inflammation, and cardiovascular events. J Am Acad Dermatol. 2017;77(4):650-6.e3.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"1872_CR45","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1365-2796.2010.02310.x","volume":"270","author":"O Ahlehoff","year":"2011","unstructured":"Ahlehoff O, Gislason GH, Charlot M, et al. Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study. J Intern Med. 2011;270(2):147\u201357.","journal-title":"J Intern Med"},{"issue":"3","key":"1872_CR46","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1161\/CIRCULATIONAHA.116.026859","volume":"136","author":"JB Lerman","year":"2017","unstructured":"Lerman JB, Joshi AA, Chaturvedi A, et al. Coronary plaque characterization in psoriasis reveals high-risk features that improve after treatment in a prospective observational study. Circulation. 2017;136(3):263\u201376.","journal-title":"Circulation"},{"issue":"1","key":"1872_CR47","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1001\/jamadermatol.2024.4433","volume":"161","author":"A Svedbom","year":"2025","unstructured":"Svedbom A, Mallbris L, Gonz\u00e1lez-Cantero \u00c1, et al. Skin inflammation, systemic inflammation, and cardiovascular disease in psoriasis. JAMA Dermatol. 2025;161(1):81\u20136.","journal-title":"JAMA Dermatol"},{"issue":"2","key":"1872_CR48","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000062","volume":"2","author":"EJ Armstrong","year":"2013","unstructured":"Armstrong EJ, Harskamp CT, Armstrong AW. Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies. J Am Heart Assoc. 2013;2(2):e000062.","journal-title":"J Am Heart Assoc"},{"key":"1872_CR49","doi-asserted-by":"publisher","first-page":"1044117","DOI":"10.3389\/fcvm.2022.1044117","volume":"9","author":"H Wu","year":"2022","unstructured":"Wu H, Luo Z, Liu J, Luo D, Song L, Zhao Y. Association between psoriasis and coronary artery calcification: a systematic review and meta-analysis. Front Cardiovasc Med. 2022;9:1044117.","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"1872_CR50","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s11845-025-03875-x","volume":"194","author":"M Yousefi","year":"2025","unstructured":"Yousefi M, Shakeri P, Tahvildari A, Omran HS, Sharifi S, Shafiee MA. Exploring the association between psoriasis and subclinical atherosclerosis defined by carotid intima-media thickness (CIMT) in patients with psoriasis vulgaris: a systematic review and meta-analysis. Ir J Med Sci. 2025;194(2):475\u201389.","journal-title":"Ir J Med Sci"},{"issue":"34","key":"1872_CR51","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","volume":"42","author":"FLJ Visseren","year":"2021","unstructured":"Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227\u2013337.","journal-title":"Eur Heart J"},{"issue":"7","key":"1872_CR52","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.amjcard.2011.11.025","volume":"109","author":"AW Armstrong","year":"2012","unstructured":"Armstrong AW, Harskamp CT, Ledo L, Rogers JH, Armstrong EJ. Coronary artery disease in patients with psoriasis referred for coronary angiography. Am J Cardiol. 2012;109(7):976\u201380.","journal-title":"Am J Cardiol"},{"issue":"4","key":"1872_CR53","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/j.1365-2133.2011.10774.x","volume":"166","author":"WQ Li","year":"2012","unstructured":"Li WQ, Han JL, Manson JE, et al. Psoriasis and risk of nonfatal cardiovascular disease in U.S. women: a cohort study. Br J Dermatol. 2012;166(4):811\u20138.","journal-title":"Br J Dermatol"},{"issue":"12","key":"1872_CR54","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.jacc.2007.03.067","volume":"50","author":"JK Min","year":"2007","unstructured":"Min JK, Shaw LJ, Devereux RB, et al. Prognostic value of multidetector coronary computed tomographic angiography for prediction of all-cause mortality. J Am Coll Cardiol. 2007;50(12):1161\u201370.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"1872_CR55","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1136\/annrheumdis-2016-210390","volume":"76","author":"J Shen","year":"2017","unstructured":"Shen J, Wong K-T, Cheng IT, et al. Increased prevalence of coronary plaque in patients with psoriatic arthritis without prior diagnosis of coronary artery disease. Ann Rheum Dis. 2017;76(7):1237\u201344.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1872_CR56","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/art.40389","volume":"70","author":"A Szentpetery","year":"2018","unstructured":"Szentpetery A, Healy GM, Brady D, et al. Higher coronary plaque burden in psoriatic arthritis is independent of metabolic syndrome and associated with underlying disease severity. Arthritis Rheumatol. 2018;70(3):396\u2013407.","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"1872_CR57","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1161\/CIRCIMAGING.113.001047","volume":"7","author":"MS Bittencourt","year":"2014","unstructured":"Bittencourt MS, Hulten E, Ghoshhajra B, et al. Prognostic value of nonobstructive and obstructive coronary artery disease detected by coronary computed tomography angiography to identify cardiovascular events. Circ Cardiovasc Imaging. 2014;7(2):282\u201391.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"6","key":"1872_CR58","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.jcmg.2024.12.004","volume":"18","author":"R Vergallo","year":"2025","unstructured":"Vergallo R, Park S-J, Stone GW, et al. Vulnerable or high-risk plaque. JACC Cardiovasc Imaging. 2025;18(6):709\u201340.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"5","key":"1872_CR59","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00059-011-3547-z","volume":"37","author":"B Enany","year":"2012","unstructured":"Enany B, El Zohiery AK, Elhilaly R, Badr T. Carotid intima-media thickness and serum leptin in psoriasis. Herz. 2012;37(5):527\u201333.","journal-title":"Herz"},{"issue":"6","key":"1872_CR60","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1111\/jdv.19900","volume":"38","author":"N\u00c1 Galajda","year":"2024","unstructured":"Galajda N\u00c1, Meznerics FA, M\u00e1trai P, et al. Reducing cardiovascular risk in immune-mediated inflammatory diseases: tumour necrosis factor inhibitors compared to conventional therapies\u2014a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2024;38(6):1070\u201388.","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01872-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-026-01872-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01872-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:03:12Z","timestamp":1788984192000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-026-01872-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":60,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1872"],"URL":"https:\/\/doi.org\/10.1007\/s13555-026-01872-1","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]},"assertion":[{"value":"5 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Bernadett B Huszti, No\u00e9mi \u00c1 Galajda, Seo-Ho Cho, M\u00e1ria V Kolonics, \u00c9va A Piros, Andrea Luk\u00e1cs, B\u00e1lint Szilveszter, Borb\u00e1la Vattay, Kl\u00e1ra Szalai, Andr\u00e1s B\u00e1nv\u00f6lgyi, Lajos V Kem\u00e9ny, P\u00e1l Maurovich Horvat, Adrienn K Po\u00f3r, B\u00e9la Merkely, P\u00e9ter Holl\u00f3 have nothing to disclose.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the Regional Institutional Scientific and Research Committee of Semmelweis University, Budapest, Hungary (SE RKEB: 154\/2019). The study was conducted in accordance with the Declaration of Helsinki. All enrolled patients provided informed consent. The patients in this manuscript have given written informed consent to the publication of their case details.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}